Literature DB >> 10198308

Insulin but not growth hormone stimulates protein anabolism in skin wound and muscle.

X J Zhang1, D L Chinkes, S E Wolf, R R Wolfe.   

Abstract

We have measured protein kinetics in the scalded skin and normal muscle in anesthetized rabbits. On the 7th day after ear scald, L-[ring-13C6]phenylalanine was infused as a tracer, and the ear and hindlimb were used as arteriovenous units to reflect skin and muscle protein kinetics. Insulin was infused at 0.6 or 2.3-3.4 mU. kg-1. min-1 in the low-dose and high-dose insulin groups. In the growth hormone group, recombinant human growth hormone was administered at 2 mg. kg-1. day-1 after the ear was scalded. The results were compared with a control group in which the ear was scalded but otherwise was not treated. In the control group, net protein loss in the scalded skin and muscle was 23.1 +/- 21.4 and 3.9 +/- 1.5 micromol. 100 g-1. h-1, respectively. Insulin infusion at either high or low dose reduced net protein loss to near zero by inhibiting proteolysis. In contrast, growth hormone treatment had no anabolic effect on either tissue. In conclusion, insulin but not growth hormone has an anabolic effect on scalded skin and normal muscle; low-dose insulin is as effective in achieving an anabolic effect on both tissues, with less hypoglycemic response than high-dose insulin.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10198308     DOI: 10.1152/ajpendo.1999.276.4.E712

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  15 in total

1.  Intensive insulin therapy in severely burned pediatric patients: a prospective randomized trial.

Authors:  Marc G Jeschke; Gabriela A Kulp; Robert Kraft; Celeste C Finnerty; Ron Mlcak; Jong O Lee; David N Herndon
Journal:  Am J Respir Crit Care Med       Date:  2010-04-15       Impact factor: 21.405

2.  Nutrition, anabolism, and the wound healing process: an overview.

Authors:  Robert H Demling
Journal:  Eplasty       Date:  2009-02-03

Review 3.  Glycemic control in the burn intensive care unit: focus on the role of anemia in glucose measurement.

Authors:  Elizabeth A Mann; Alejandra G Mora; Heather F Pidcoke; Steven E Wolf; Charles E Wade
Journal:  J Diabetes Sci Technol       Date:  2009-11-01

4.  Anabolic effects of oxandrolone after severe burn.

Authors:  D W Hart; S E Wolf; P I Ramzy; D L Chinkes; R B Beauford; A A Ferrando; R R Wolfe; D N Herndon
Journal:  Ann Surg       Date:  2001-04       Impact factor: 12.969

5.  Intensive insulin treatment increases donor site wound protein synthesis in burn patients.

Authors:  Demidmaa Tuvdendorj; Xiao-Jun Zhang; David L Chinkes; Asle Aarsland; Gabriela A Kulp; Marc G Jeschke; David N Herndon
Journal:  Surgery       Date:  2011-01-14       Impact factor: 3.982

Review 6.  What, how, and how much should patients with burns be fed?

Authors:  Felicia N Williams; Ludwik K Branski; Marc G Jeschke; David N Herndon
Journal:  Surg Clin North Am       Date:  2011-06       Impact factor: 2.741

Review 7.  Postburn Hypermetabolism: Past, Present, and Future.

Authors:  Marc G Jeschke
Journal:  J Burn Care Res       Date:  2016 Mar-Apr       Impact factor: 1.845

Review 8.  Insulin resistance postburn: underlying mechanisms and current therapeutic strategies.

Authors:  Gerd G Gauglitz; David N Herndon; Marc G Jeschke
Journal:  J Burn Care Res       Date:  2008 Sep-Oct       Impact factor: 1.845

9.  Hypoglycemia is associated with increased postburn morbidity and mortality in pediatric patients.

Authors:  Marc G Jeschke; Ruxandra Pinto; David N Herndon; Celeste C Finnerty; Robert Kraft
Journal:  Crit Care Med       Date:  2014-05       Impact factor: 7.598

10.  Influence of insulin and muscle fiber type in nepsilon-(carboxymethyl)-lysine accumulation in soleus muscle of rats with streptozotocin-induced diabetes mellitus.

Authors:  LeAnn M Snow; Ladora V Thompson
Journal:  Pathobiology       Date:  2009-10-02       Impact factor: 4.342

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.